Valuation Decoy Therapeutics Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-09-01 EDT			5-day change	1st Jan Change
3.060 ^USD	+0.33%		+2.68%	-60.70%

08-12	Decoy Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-27	Decoy Therapeutics Demonstrates In Vitro Activity Of D-MAV Candidate Against Wild-Type Ebola Zaire Virus And Opens Exploratory Program To Design D-MAVs Against Filoviruses Including Ebola And Marburg	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	21.65	22.39	3.485	2.56	2.652	4.142
Change	-	3.4%	-84.43%	-26.55%	3.58%	56.21%
Enterprise Value (EV) ¹	11.01	-6.823	-8.621	-3.05	0.4389	-6.568
Change	-	-161.96%	-26.35%	64.62%	114.39%	-1,596.36%
P/E	-	-	-	-	-	-0.06x
PBR	-	0.58x	-	-	-	0.7x
PEG	-	-	-	-	-	-
Capitalization / Revenue	4.14x	12.2x	-	-	-	-
EV / Revenue	2.1x	-3.71x	-	-	-	-
EV / EBITDA	-1.42x	0.53x	0.38x	0.24x	-0.08x	1.61x
EV / EBIT	-1.41x	0.53x	0.38x	0.24x	-0.08x	1.6x
EV / FCF	-1.26x	1.76x	0.6x	0.34x	-0.15x	-3.6x
FCF Yield	-79.6%	57%	167%	295%	-674%	-27.7%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-	-	-	-	-	-129.1
Distribution rate	-	-	-	-	-	-
Net sales ¹	5.233	1.84	-	-	-	-
EBITDA ¹	-7.768	-12.79	-22.97	-12.88	-5.73	-4.089
EBIT ¹	-7.786	-12.81	-22.98	-12.89	-5.734	-4.096
Net income ¹	-7.352	-12.77	-31.61	-12.54	-5.576	-12.52
Net Debt ¹	-10.64	-29.21	-12.11	-5.61	-2.213	-10.71
Reference price ²	32,759.974	17,841.586	2,203.200	936.000	331.200	7.786
Nbr of stocks (in thousands)	0.66	1.26	1.58	2.74	8.01	532
Announcement Date	3/18/21	3/25/22	3/27/23	3/22/24	3/21/25	3/31/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
DECOY THERAPEUTICS INC.	-	-	-	-	2M
WUXI APPTEC CO., LTD.	20.2x	7.1x	14.34x	1.44%	68.21B
ARGENX SE	36.48x	9.51x	29x	0.04%	64.25B
INSMED INCORPORATED	-74.38x	14.34x	-69.16x	-.--%	26.54B
BIONTECH SE	-15.61x	5.93x	-7.46x	-.--%	25.61B
GENMAB A/S	27.16x	5.09x	16.92x	-.--%	19.88B
PHARMAESSENTIA CORPORATION	49.41x	18.23x	36.98x	0.31%	17.13B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1290.27x	37.31x	814.28x	-.--%	14.93B
EXELIXIS, INC.	17.57x	5.23x	12.21x	-.--%	14.1B
MADRIGAL PHARMACEUTICALS, INC.	-85.32x	7.81x	-64.69x	-.--%	12.45B
Average	140.64x	12.28x	86.94x	0.2%	26.31B
Weighted average by Cap.	80.53x	10.52x	50.59x	0.4%